Literature DB >> 10965007

Predictors of outcome in severe, asymptomatic aortic stenosis.

R Rosenhek1, T Binder, G Porenta, I Lang, G Christ, M Schemper, G Maurer, H Baumgartner.   

Abstract

BACKGROUND: Whether to perform valve replacement in patients with asymptomatic but severe aortic stenosis is controversial. Therefore, we studied the natural history of this condition to identify predictors of outcome.
METHODS: During 1994, we identified 128 consecutive patients with asymptomatic, severe aortic stenosis (59 women and 69 men; mean [+/-SD] age, 60+/-18 years; aortic-jet velocity, 5.0+/-0.6 m per second). The patients were prospectively followed until 1998.
RESULTS: Follow-up information was available for 126 patients (98 percent) for a mean of 22+/-18 months. Event-free survival, with the end point defined as death (8 patients) or valve replacement necessitated by the development of symptoms (59 patients), was 67+/-5 percent at one year, 56+/-5 percent at two years, and 33+/-5 percent at four years. Five of the six deaths from cardiac disease were preceded by symptoms. According to multivariate analysis, only the extent of aortic-valve calcification was an independent predictor of outcome, whereas age, sex, and the presence or absence of coronary artery disease, hypertension, diabetes, and hypercholesterolemia were not. Event-free survival for patients with no or mild valvular calcification was 92+/-5 percent at one year, 84+/-8 percent at two years, and 75+/-9 percent at four years, as compared with 60+/-6 percent, 47+/-6 percent, and 20+/-5 percent, respectively, for those with moderate or severe calcification. The rate of progression of stenosis, as reflected by the aortic-jet velocity, was significantly higher in patients who had cardiac events (0.45+/-0.38 m per second per year) than those who did not have cardiac events (0.14+/-0.18 m per second per year, P<0.001), and the rate of progression of stenosis provided useful prognostic information. Of the patients with moderately or severely calcified aortic valves whose aortic-jet velocity increased by 0.3 m per second or more within one year, 79 percent underwent surgery or died within two years of the observed increase.
CONCLUSIONS: In asymptomatic patients with aortic stenosis, it appears to be relatively safe to delay surgery until symptoms develop. However, outcomes vary widely. The presence of moderate or severe valvular calcification, together with a rapid increase in aortic-jet velocity, identifies patients with a very poor prognosis. These patients should be considered for early valve replacement rather than have surgery delayed until symptoms develop.

Entities:  

Mesh:

Year:  2000        PMID: 10965007     DOI: 10.1056/NEJM200008313430903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  214 in total

1.  Surgery in asymptomatic aortic stenosis.

Authors:  Gerald P McCann; W Stewart Hillis
Journal:  BMJ       Date:  2004-01-10

Review 2.  Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Authors:  Nalini M Rajamannan; Bernard Gersh; Robert O Bonow
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

Review 3.  Multidetector-row CT: cardiosurgery indications.

Authors:  Christopher Herzog; Selami Dogan; Gerhard Wimmer-Greinecker; Joern O Balzer; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

4.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 5.  Cardiac imaging in valvular heart disease.

Authors:  W S Choo; R P Steeds
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 6.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

7.  [The "asymptomatic" patient with chronic acquired heart valve disease].

Authors:  D Horstkotte; C Prinz; C Piper
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

8.  Three dimensional volume quantification of aortic valve calcification using multislice computed tomography.

Authors:  G J Morgan-Hughes; P E Owens; C A Roobottom; A J Marshall
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

9.  Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves.

Authors:  Edit Nagy; Yang Lei; Eduardo Martínez-Martínez; Simon C Body; Florian Schlotter; Michael Creager; Alexander Assmann; Kamal Khabbaz; Peter Libby; Göran K Hansson; Elena Aikawa
Journal:  Am J Pathol       Date:  2017-04-19       Impact factor: 4.307

10.  Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice.

Authors:  Teruko Tashiro; Sorin V Pislaru; Jodi M Blustin; Vuyisile T Nkomo; Martin D Abel; Christopher G Scott; Patricia A Pellikka
Journal:  Eur Heart J       Date:  2014-02-19       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.